Animal studies suggest that EPO may be protective in diet-induced obesity, improves glucose tolerance, reduces insulin resistance and regulates fat mass accumulation, particularly in male mice (Wang et al., 2014; Zhang et al., 2014; Alnaeeli and Noguchi, 2015). This evidence concerns the gene EPO and obesity due to melanocortin 4 receptor deficiency.